With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement. The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders. It shows prior to the pandemic half

As Australia enters a new phase of its COVID-19 journey, governments have an increasing opportunity to engage in a two-way conversation with GPs; not only about the virus itself but also about ensuring their patients don’t ignore their general health during the pandemic.  GPs are generally satisfied with the COVID-19 information they have received up to now, according to a survey of AusDoc.PLUS readers1. But a big gripe is that different information sources

To download a PDF version of this infographic, please click here.

Two weeks ago, on 17 March, as governments around the world began closing borders, a flight arrived at Sydney airport from the US. On board was the first consignment of thousands of new COVID-19 diagnostic testing kits that had been developed by Roche Diagnostics within weeks of the outbreak in Wuhan, China. Their arrival was

GP practices across Australia are rising to the challenge of COVID-19. By far, the most widely read Australian Doctor article this week is a Quick Guide to Medicare funding for telehealth consultations. A close second is a recent article that that discusses the impact of the pandemic on day-to-day practice. Other articles and reader comments